Trial
NCT00738088
Variation in Sulphonylurea Response in Type 2 Diabetes
Phase IVTERMINATEDREGULATORYConfidence: HIGH
Sponsor
NHS Tayside
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
gliclazide
Why stopped
Following Regulator inspection in 2009, study terminated as inadequate approvals were in place
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-03